Suncoast Equity Management Abb Vie Inc. Transaction History

Suncoast Equity Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $1.06 Million - $1.35 Million	-7,716 Closed	0 $0
Q1 2022 Apr 26, 2022	BUY	$131.98 - $163.75 $64,142 - $79,582	486 Added 6.72%	7,716 $1.25 Million
Q4 2021 Jan 28, 2022	BUY	$107.43 - $135.93 $45,120 - $57,090	420 Added 6.17%	7,230 $979,000
Q3 2021 Oct 29, 2021	SELL	$106.4 - $120.78 $68,096 - $77,299	-640 Reduced 8.59%	6,810 $735,000
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $169,914 - $189,294	1,615 Added 27.68%	7,450 $839,000
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $10,741 - $11,825	105 Added 1.83%	5,835 $631,000
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $35,818 - $48,358	445 Added 8.42%	5,730 $614,000
Q3 2020 Oct 22, 2020	BUY	$85.91 - $100.83 $17,182 - $20,166	200 Added 3.93%	5,285 $463,000
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $58,696 - $78,544	800 Added 18.67%	5,085 $499,000
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $276,382 - $419,030	4,285 New	4,285 $326,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Suncoast Equity Management, based on Form 13F filings with the SEC.

Stay updated on Suncoast Equity Management with notifications on news.